Cargando…
Clinical implementation of RNA signatures for pharmacogenomic decision-making
RNA profiling is increasingly used to predict drug response, dose, or toxicity based on analysis of drug pharmacokinetic or pharmacodynamic pathways. Before implementing multiplexed RNA arrays in clinical practice, validation studies are carried out to demonstrate sufficient evidence of analytic and...
Autores principales: | Tang, Weihua, Hu, Zhiyuan, Muallem, Hind, Gulley, Margaret L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513222/ https://www.ncbi.nlm.nih.gov/pubmed/23226056 http://dx.doi.org/10.2147/PGPM.S14888 |
Ejemplares similares
-
The reality of pharmacogenomics: optimizing therapeutic decision making.
por: Lee, Craig R, et al.
Publicado: (2003) -
Pharmacogenomic Testing: Clinical Evidence and Implementation Challenges
por: Hippman, Catriona, et al.
Publicado: (2019) -
A critical analysis of barriers to the clinical implementation of pharmacogenomics
por: McKinnon, Ross A, et al.
Publicado: (2007) -
Implementing pharmacogenomics decision support across seven European countries: The Ubiquitous Pharmacogenomics (U-PGx) project
por: Blagec, Kathrin, et al.
Publicado: (2018) -
Pharmacogenomic testing in paediatrics: Clinical implementation strategies
por: Barker, Charlotte I. S., et al.
Publicado: (2022)